SO
REGN icon

Sierra Ocean’s Regeneron Pharmaceuticals REGN Stock Holding History

Sierra Ocean’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19
Closed -$9.97K – 751
2025
Q2 		$9.97K Buy
19
+7
+58% +$3.91K 0.01% 455
2025
Q1 		$7.61K Sell
12
-14
-54% -$9.63K 0.01% 493
2024
Q4 		$18.5K Buy
+26
New +$21.8K 0.02% 302

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sierra Ocean's REGN Position: Q3 2025 in Review

Sierra Ocean sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 19 shares — an estimated $9.97K sold.

Sierra Ocean first reported a position in REGN in Q4 2024 and held it in 3 quarters. The position peaked at $18.5K in Q4 2024. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Sierra Ocean reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Sierra Ocean sold 19 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $9.97K.
  • Sierra Ocean first reported a position in Regeneron Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Sierra Ocean's Regeneron Pharmaceuticals position peaked at $18.5K in Q4 2024.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Sierra Ocean's 13F filing for Q3 2025, filed 7 Nov 2025.